Cita APA

Asleh, K., Lluch, A., Goytain, A., Barrios, C., Wang, X., Torrecillas, L., . . . Martin, M. (2023). Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant Capecitabine.

Citación estilo Chicago

Asleh, K., et al. Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit From Extended Adjuvant Capecitabine. 2023.

Cita MLA

Asleh, K., et al. Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit From Extended Adjuvant Capecitabine. 2023.